Biocept, Inc. is a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and biomarker analysis, headquartered in San Diego, California.
Biocept's mission is to improve outcomes for cancer patients by advancing oncology diagnostics.
Biocept utilizes patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. Additionally, Biocept offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies, and clinical trial support.Find a broker to begin trading BIOC now
|Avg. Daily Vol. (3m)||1,790,797|
|As of May. 23, 2017|